Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way. The Executive Director, Health Technology serves as the enterprise technical expert focused on accelerating the adoption and integration of Madrigal therapies within health system infrastructure, particularly Electronic Health Records (EHRs), clinical decision support tools, and digital workflows across Integrated Delivery Networks (IDNs). This role will partner with Market Access, Medical, Marketing, Diagnostics, and Key Account Directors (KADs) to enable and operationalize pathway and protocol implementation through technology. The individual will work directly with health systems to ensure that approved protocols, diagnostics, and treatment pathways are effectively embedded into EHRs and care delivery workflows, reducing friction and accelerating time to therapy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive